Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway.
10.19540/j.cnki.cjcmm.20221014.703
- Author:
Li WANG
1
;
Fang LI
1
;
Ni-Ni GU
1
;
Hui SHEN
1
;
Cai-Li HAN
1
;
Kai-Yang LI
1
;
Rui-Yang YAN
1
;
Jue WANG
1
;
Zhi-Kuan MI
1
Author Information
1. Medical School of Yan'an University Yan'an 716000, China.
- Publication Type:Journal Article
- Keywords:
5-fluorouracil;
chemoresistance;
colorectal cancer;
hydroxysafflor yellow A;
proliferation and migration
- MeSH:
Humans;
Proto-Oncogene Proteins c-akt/metabolism*;
Drug Resistance, Neoplasm;
Cell Line, Tumor;
TOR Serine-Threonine Kinases/metabolism*;
Fluorouracil/pharmacology*;
Cell Proliferation;
Autophagy;
Colorectal Neoplasms/drug therapy*
- From:
China Journal of Chinese Materia Medica
2023;48(2):517-524
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, the clinical treatment of colorectal cancer(CRC) has made great progress, but chemoresistance is still one of the main reasons for reducing the survival rate of patients with colorectal cancer. Therefore, ameliorating chemotherapy resis-tance is an urgent problem to be solved. The purpose of this study was to investigate the regulatory role and related molecular mechanisms of hydroxysafflor yellow A(HSYA) in colorectal cancer cell proliferation, migration, and 5-fluorouracil(5-FU) chemoresistance. In this study, HCT116 and HT-29 cells were used as research subjects. Firstly, methyl thiazolyl tetrazolium(MTT) assay and colony formation assay were used to detect and analyze the effect of HSYA on the proliferation of CRC cells. Secondly, the effect of HSYA on the cell cycle in CRC cells was analyzed by cell cycle assay. Furthermore, the effect of HSYA on the migration of CRC cells was analyzed by wound-healing assay and Transwell assay. Based on the above, the influences of HSYA on 5-FU chemoresistance of CRC cells and related molecular mechanisms were explored and analyzed. The results showed that HSYA significantly inhibited the proliferation and migration of CRC cells, and arrested the cell cycle in G_0/G_1 phase. In addition, HSYA significantly ameliorated the chemoresistance of CRC cells to 5-FU. The results of acridine orange staining and Western blot showed that the autophagy activity of CRC cells in the HSYA and 5-FU combined treatment group was significantly higher than that in the 5-FU single drug treatment group. As compared with the 5-FU single drug treatment group, the phosphorylation levels of protein kinase B(Akt) and mammalian target of rapamycin(mTOR) in the HSYA and 5-FU combined treatment group were significantly reduced, indicating that the Akt/mTOR signaling pathway in the combined treatment group was down-regulated in CRC cells. In conclusion, HSYA may upregulate autophagy activity through the Akt/mTOR signaling pathway, thereby inhibiting the proliferation and migration of CRC cells and ameliorating the chemoresistance to 5-FU.
